---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-021038"
form_type: "8-K"
ticker: "CRVO"
cik: "0001053691"
company_name: "CervoMed Inc."
filed_at: "2026-06-18T11:21:33+00:00"
generated_at: "2026-06-18T11:25:10.929269+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# CervoMed receives US patent allowance for neflamapimod in dementia with Lewy bodies

## Summary
- USPTO notice of allowance for patent covering neflamapimod for dementia with Lewy bodies in patients without substantial Alzheimer's tau pathology.
- Expected to provide intellectual property protection into 2042, excluding potential patent term extension.
- Patent protects use of drug candidate neflamapimod for this specific patient population.

## SEC filing metadata
- accession: 0001437749-26-021038
- form_type: 8-K
- ticker: CRVO
- cik: 0001053691
- company_name: CervoMed Inc.
- filed_at: 2026-06-18T11:21:33+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1053691/000143774926021038/0001437749-26-021038-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1053691/000143774926021038/crvo20260618c_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-021038
- JSON: https://secwatch.observer/filing/0001437749-26-021038.json
- Plain text: https://secwatch.observer/filing/0001437749-26-021038.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.